Evidence map›Paper›PMID 21467202›Full record

ArticleHuman reproduction (Oxford, England)2011

Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study.

A Iversen, I Thune, A McTiernan, A Emaus, S E Finstad, V Flote, T Wilsgaard, S F Lipson, P T Ellison, G Jasienska and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Human reproduction (Oxford, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Current issues in molecular biology · 2023
    Review
  4. Metabolic Syndrome in Breast Cancer Patients: An Observational Study.Breast cancer : basic and clinical research · 2021
    Article
  5. Article
  6. Article
  7. Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2016
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

A IversenDepartment of Community Medicine, Faculty of Health Sciences, University of Tromsø, N-9037 Tromsø, Norway. anita.iversen@uit.no
I Thune
A McTiernan
A Emaus
S E Finstad
V Flote
T Wilsgaard
S F Lipson
P T Ellison
G Jasienska
A-S Furberg
UiT The Arctic University of Norway · NOOslo University Hospital · NOHarvard University · USFred Hutch Cancer Center · USUniversity School of Physical Education in Kraków · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOvarian hormones, parity and length of 'menarche-to-first birth' time interval are known risk factors for breast cancer, yet the associations between 17β-estradiol, progesterone and these reproductive factors remain unclear.

methodsA total of 204 women (25-35 years) who participated in the Norwegian EBBA-I study collected daily saliva samples for one complete menstrual cycle, and filled in a reproductive history questionnaire. Anthropometry was measured and saliva samples were analyzed for ovarian hormones. Associations between parity, the interval and ovarian hormones, and effects of hormone-related lifestyle factors were studied in linear regression models.

resultsMean age was 30.7 years, and age of menarche 13.1 years. Parous women had on average 1.9 births, and age at first birth was 24.5 years. No association was observed between parity and ovarian steroids. In nulliparous women, higher waist circumference (≥ 77.75 cm) and longer oral contraceptive (OC) use (≥ 3 years) were associated with higher levels of 17β-estradiol. Short (<10 years) versus long (>13.5 years) 'menarche-to-first birth' interval was associated with higher overall mean (P(trend) = 0.029), 47% higher maximum peak and 30% higher mid-cycle levels of 17β-estradiol. We observed a 2.6% decrease in overall mean salivary 17β-estradiol with each 1-year increase in the interval.

conclusionsNulliparous women may be more susceptible to lifestyle factors, abdominal overweight and past OC use, influencing metabolic and hormonal profiles and thus breast cancer risk. Short time between 'menarche-to-first birth' is linked to higher ovarian hormone levels among regularly cycling women, suggesting that timing of first birth is related to fecundity.

Indexed as

AdolescentAdultBreast NeoplasmsContraceptives, Oral, HormonalEstradiolFemaleFertilityHumansMenarcheMenstrual CycleNorwayParityPregnancyPremenopauseProgesteroneSalivaContraceptives, Oral, HormonalEstradiolProgesterone

Identifiers

PMID21467202
PMCPMC3096559
OpenAlexW2163937525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.